首页> Frontiers in immunology> The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell Development.

The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell Development.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mirte,Post

第一单位： Institute of Vascular Biology and Thrombosis Research, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.

作者： Mirte,Post ^[1] ; Angelica,Cuapio ^[1] ; Markus,Osl ^[1] ; Dorit,Lehmann ^[1] ; Ulrike,Resch ^[1] ; David M,Davies ^[2] ; Martin,Bilban ^[3] ; Bernhard,Schlechta ^[4] ; Wolfgang,Eppel ^[4] ; Amit,Nathwani ^[2] ; Dagmar,Stoiber ^[5] ; Jan,Spanholtz ^[6] ; Emilio,Casanova ^[7] ; Erhard,Hofer ^[1]

作者单位： Institute of Vascular Biology and Thrombosis Research, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria. ^[1] Department of Oncology, University College London Cancer Institute, London, UK. ^[2] Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. ^[3] Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria. ^[4] Ludwig Boltzmann Institute of Cancer Research, Vienna, Austria.;Institute of Pharmacology, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria. ^[5] Glycostem Therapeutics, Oss, Netherlands. ^[6] Ludwig Boltzmann Institute of Cancer Research, Vienna, Austria.;Institute of Physiology, Center of Physiology and Pharmacology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. ^[7]

关键词 CD56 NK-cell development ZNF683/HOBIT ex vivo differentiation natural killer cells

DOI 10.3389/fimmu.2017.00535

PMID 28555134

发布时间 2025-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交